Articles

Manchin’s Deal Won’t Save The Democrats In The Midterms

August 04, 2022
00e27213ec14fb6606cb36ac7714ec4f

Hope springs eternal, especially among politicians facing an electoral wipeout. Democratic leaders and their media confederates quickly embraced the latest life-preserver: the recent deal between Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D., W.Va.) to resurrect the Build Back Better Bill.

The two senators slimmed down the legislative monstrosity and restyled it the Inflation Reduction Act. That nonsense label is worthy of a P.T. Barnum ad campaign. The Penn Wharton Budget Model predicts that the bill’s impact on inflation will be “statistically indistinguishable from zero.”

It isn’t clear this slimmer bill can pass, but already the Washington Post has trumpeted the hodgepodge of climate provisions, a three-year extension of ObamaCare subsidies, and price controls on some drugs provided through Medicare as having “the potential to change the narrative” of Joe Biden’s presidency.

Mr. Biden needs all the help he can get: His 38% approval rating in a late July Gallup Poll is down from the 40% average in the sixth quarter of his presidency, itself the lowest figure for any president since Gallup began routinely measuring in the 1950s.

So Democrats are pumping this latest Build Back Better incarnation big time, hoping it’ll be the life raft they need. A White House spokesman says it shows “Democrats have a plan to lower costs for middle class families.” Retiring Illinois Rep. Cheri Bustos claims it gives her party “the Big MO,” while Virginia Rep. Abigail Spanberger proclaimed it will “change people’s lives.”

Such hyperbole won’t save Democrats; voters will see that the promises don’t match reality. Take California Rep. Mike Levin’s claim that the bill “will dramatically reduce costs for the average American that has to pay exorbitant prices for prescription drugs.” These price controls would apply only to expensive drugs with no generic competition offered through Medicare, starting with 10 such drugs in 2026. Consumers won’t feel any cost difference ahead of the midterms.

That’s a major problem for a bill claiming to ease the high prices fueling voter frustration. This $485 billion legislation won’t reduce inflation in the near term and could even make it slightly worse.

Like last year’s version of Build Back Better, the bill also has cost-hiding gimmicks. Take the ObamaCare subsidies that the American Rescue Plan extended for a year. The new bill would extend them for three more years, though Democrats almost certainly intend them to be permanent. This “temporary” extension allows Democrats to pretend this measure would cost only $65 billion, concealing the $155 billion the expansion would cost for the rest of the decade. Voters didn’t like this hocus-pocus when Democrats tried it last year, and now they’ve also seen what unnecessary spending does to inflation.

The bill is also likely to harm growth with its $470 billion in revenue increases via new taxation. As Republicans will surely note again and again, that’s the last thing Washington should be doing during a recession. And so much for Mr. Biden’s promise never to raise taxes on families making less than $400,000. Analysis from the Joint Tax Committee says taxes on families making less than $100,000 a year will rise by $5.8 billion in 2023 and taxes on those making less than $500,000 a year will jump by $30.8 billion.

 

Democrats seem to know this strategy isn’t sufficient. Even while arguing that the bill’s passage will “make the Democratic closing argument stronger,” Simon Rosenberg, president of NDN, a progressive think tank, admits that would only give “a point or two” to Democratic candidates. That’s simply not enough. It’s also already hard for Democratic candidates, especially in the House, to put daylight between themselves and Mr. Biden. This bill binds them tighter to the president and his dismal poll numbers.

But while the strategic picture could hardly be better for Republicans, they face serious tactical challenges that may allow Democrats to save seats, particularly in the Senate. While Republican Party committees and super PACs have a cash-on-hand advantage over their Democratic counterparts, Democrats have a better small-dollar fundraising machine, giving their candidates a fundraising advantage. Moreover, the most important factor in any race is candidate quality, and the GOP has nominated some doozies. Consider Tuesday’s primaries: While Republicans avoided a disaster in the Missouri Senate race, they nominated controversial figures for governor, senator and secretary of state in Arizona and put a swing House seat at risk in Michigan.

Every candidate, good or bad, is under pressure in the general election, which is coming up fast. Absentee voting starts in six weeks, Election Day is about three months off, and plenty of contests are up in the air. The Schumer-Manchin deal won’t save the Democrats. But unhinged GOP candidates might.

Read More at the WSJ

Related Article

Placeholder article
November 24, 2022 |
Article
A novel explanation for the GOP’s disappointing midterm comes from Missouri Sen. Josh Hawley. ...
Cd6625710a846c07c22d68e92c9bd04e
November 17, 2022 |
Article
Donald Trump hates not being the center of attention. ...
3f9d6bb13be0dbe92c3638a6b0b07f5c
November 10, 2022 |
Article
The red wave never came. What happened in Tuesday’s midterms was closer to a trickle. ...
Ced568f9c1f2a5fb1f202ea7393bb1b7
November 03, 2022 |
Article
Here’s what I’ll be looking for Tuesday as I watch election returns at Fox News in New York.   ...
Button karlsbooks
Button readinglist
Button nextapperance